NBIX director granted 2,567 RSUs
POPS RICHARD F reported acquisition or exercise transactions in this Form 4 filing.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
POPS RICHARD F reported acquisition or exercise transactions in this Form 4 filing.
NEUROCRINE BIOSCIENCES INC director Richard F. Pops received a grant of 2,567 Restricted Stock Units (RSUs). Each RSU represents one share of common stock upon vesting, and all 2,567 RSUs are scheduled to vest in full on May 27, 2027. Following this compensation award, Pops holds 2,567 RSUs directly.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Restriced Stock Unit | 2,567 | $0.00 | $0.00 |
Footnotes (2)
- F1. Each Restricted Stock Unit ("RSU") represents the right to receive one share of the Issuer's common stock upon vesting.
- F2. The RSUs will vest in full on May 27, 2027.
Key Figures
Key Terms
Restricted Stock Unit financial
RSU financial
vesting financial
grant/award acquisition financial
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What insider transaction did NBIX director Richard F. Pops report?
When do Richard F. Pops’ NBIX RSUs vest?
How many NEUROCRINE BIOSCIENCES RSUs does Richard F. Pops hold after this Form 4?
Is the NBIX insider transaction a purchase or a compensation grant?
What does each NBIX Restricted Stock Unit represent in this Form 4?
AI-generated analysis. How Rhea-AI works. Not financial advice.